# Does The Surfactant Administration by Aerosolization Effective?

> **NCT02825953** · NA · UNKNOWN · sponsor: **nihat demir** · enrollment: 75 (estimated)

## Conditions studied

- Respiratory Distress Syndrome
- Surfactant Administration by Aerosolization

## Interventions

- **DRUG:** surfactant
- **DEVICE:** nasal continuous positive airway pressure
- **DEVICE:** non-invasive intermittent positive-pressure ventilation
- **DEVICE:** Neopuff
- **DEVICE:** neonatal ventilator

## Key facts

- **NCT ID:** NCT02825953
- **Lead sponsor:** nihat demir
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825953, "Does The Surfactant Administration by Aerosolization Effective?". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02825953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*